Yujiang Fang

3.1k citations
116 papers · 2.4k indexed · h-index 24
Topics
Immunotherapy and Immune Responses (17 papers)Cancer Immunotherapy and Biomarkers (13 papers)Cytokine Signaling Pathways and Interactions (12 papers)

In The Last Decade

Yujiang Fang

106 papers receiving 2.3k citations

Peers

Yujiang Fang
Comparison fields: 5 of 122
  • Immunology 873
  • Molecular Biology 755
  • Oncology 726
  • Cancer Research 235
  • Epidemiology 217
Replace Xiaomin Zhang with:
Xiaomin Zhang China
Jeong‐Heon Cha South Korea
Urban Švajger Slovenia
Juan Fang China
Hae Ryoun Park South Korea
Navneet K. Dhillon United States
Jae Jin Lee South Korea
Feng Xue China
Giusi Irma Forte Italy
Ji Eun Oh South Korea
Yujiang Fang relative to Xiaomin Zhang China Xiaomin Zhang's profile →
Citations per field
00.5×3.3×
Xiaomin Zhang · 1×
Citations per year

Countries citing papers authored by Yujiang Fang

Since Specialization
Citations

This map shows the geographic impact of Yujiang Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujiang Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujiang Fang more than expected).

Fields of papers citing papers by Yujiang Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujiang Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujiang Fang. The network helps show where Yujiang Fang may publish in the future.

Co-authorship network of co-authors of Yujiang Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Yujiang Fang. A scholar is included among the top collaborators of Yujiang Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujiang Fang. Yujiang Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 0
5 0
6 2
7 3
8 6
9 6
10 9
11 4
12 10
13 26
14 31
15 2
16 9
17 122
18 5
19 26
20 35

About Yujiang Fang

Yujiang Fang is a scholar working on Immunology, Oncology and Geriatrics and Gerontology, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Cytokine Signaling Pathways and Interactions (12 papers). The work is most often cited by research in Immunology (873 citations), Geriatrics and Gerontology (140 citations) and Oncology (726 citations). Yujiang Fang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Qian Bai, Ziwen Zhu, Mark R. Wakefield, Michael B. Nicholl, Huaping Xiao, Helen Braley‐Mullen, Vincent G. DeMarco, Shiguang Yu, Meng Tang and Matthew Davis. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026